Inogen (INGN) Gains from Investment Securities (2012 - 2026)
Inogen (INGN) reported Gains from Investment Securities of -$1.5 million for Q1 2026, down 277.91% year-over-year from $822308.0 in Q1 2025, and down 111.72% quarter-over-quarter from -$691000.0 in Q4 2025.
Inogen (INGN) Gains from Investment Securities (2012 - 2026) Analysis & Trends
Inogen (INGN) has 15 years of Gains from Investment Securities data on file, last reported at -$1.5 million in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at -$1.5 million, down 277.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.1 million (down 230.36% YoY), and the FY2025 annual result was $125000.0, up 1150.0% from the prior year.
- Gains from Investment Securities declined to -$1.5 million in Q1 2026 per INGN's latest filing, from -$691000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $1.7 million in Q2 2025 and troughed at -$1.5 million in Q1 2026.
- A 5-year average of $130553.0 and a median of $10000.0 in 2024 frame the typical range for Gains from Investment Securities.
- On a YoY basis, Gains from Investment Securities climbed as much as 17389.79% in 2025 and fell as far as 365.77% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at -$759000.0 in 2022, then surged by 208.3% to $822000.0 in 2023, then plunged by 68.37% to $260000.0 in 2024, then sank by 365.77% to -$691000.0 in 2025, then plunged by 111.72% to -$1.5 million in 2026.
- Business Quant data shows INGN's Gains from Investment Securities at -$1.5 million in Q1 2026, -$691000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.46 Mn |
| Mar 31, 2026 | -1.46 Mn |
| Dec 31, 2025 | -691,000.00 |
| Dec 31, 2025 | -691,000.00 |
| Sep 30, 2025 | 1.01 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | 822,308.00 |
| Mar 31, 2025 | 822,308.00 |
| Dec 31, 2024 | 260,000.00 |
| Dec 31, 2024 | 260,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Dec 31, 2023 | 822,000.00 |
| Dec 31, 2023 | 822,000.00 |